[Edaily Reporter Kwon Oh Seok ] #Acryl Inc., a company specializing in AI Transformation (AX) infrastructure, is accelerating the construction of an “AI Hospital” based on its proprietary healthcare AI technology and is set to fully enter the medical AX market. The company plans to lead the AI transformation of regional, essential, and public healthcare (REP) facilities in line with the government’s “Basic AI Healthcare Strategy.”

Acryl Inc. announced on the 28th that it unveiled its strategy for building an “AI Hospital”—which integrates a healthcare foundation model, a medical data platform, and an AI agent operation solution—during its technology keynote, “Acryl NOW.”
Acryl Inc. presented a solution that connects data and AI infrastructure without requiring hospitals to replace their existing electronic medical records (EMR) or systems. The core technologies are: △ the healthcare foundation model “ALLM.H” △ the medical data platform “NADIA” △ and the AI operations platform “Jonathan.H.”
In particular, ALLM.H is a Korea-specific model trained on domestic medical textbooks, clinical guidelines, and medical laws and regulations; it demonstrated accuracy surpassing major international models by correctly answering 2,980 out of 3,009 questions from the national licensing exams for four medical specialties. Based on this, the conversational medical AI ‘Dr.GAL’ was developed to assist healthcare professionals’ decision-making by providing real-time access to drug approval information and clinical evidence.
The data platform NADIA converts fragmented EMR data into standardized data that AI can utilize, while Jonathan.H provides integrated management of the development, deployment, and operation of AI agents. Based on these technologies, Acryl Inc. supports the AI transformation of entire hospitals while also pursuing expansion into the realm of “Physical AI,” which physically performs tasks in actual clinical settings.
Currently, Acryl Inc. operates its solutions at 17 hospitals nationwide (with approximately 10,000 beds), including 11 tertiary general hospitals, and holds five types of AI medical device software approved by the Ministry of Food and Drug Safety (MFDS). The company is accelerating its expansion into domestic and international markets through a contract to supply hospital information systems with Uzbekistan’s state-owned IT firm “UzInfoCom” and participation in the Ministry of Health and Welfare’s “Korean ARPA-H” project.
Acryl Inc. official stated, “We will expand our business centered on ‘Agentic AI,’ which combines clinical knowledge with AI, and continue to explore integration with ‘Physical AI’ that interacts with real clinical environments to further advance our customized AI hospital solutions.”